Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rianot Amzat

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Primary Care|August 31, 2015
Herpes Zoster OphthalmicusJulie L Johnson, Rianot Amzat, Nicolle Martin
Clinical Nuclear Medicine|August 10, 2011
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CTRianot Amzat, Pooneh Taleghani, Bital Savir-Baruch, et al.
Molecular Imaging and Biology|April 19, 2013
Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesionsRianot Amzat, Pooneh Taleghani, Daniel L Miller, et al.
The Journal of Urology|October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trialDavid M Schuster, Peter T Nieh, Ashesh B Jani, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptakeDavid M Schuster, Pooneh A Taleghani, Peter T Nieh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Primary Care|August 31, 2015
Herpes Zoster OphthalmicusJulie L Johnson, Rianot Amzat, Nicolle Martin
Clinical Nuclear Medicine|August 10, 2011
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CTRianot Amzat, Pooneh Taleghani, Bital Savir-Baruch, et al.
Molecular Imaging and Biology|April 19, 2013
Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesionsRianot Amzat, Pooneh Taleghani, Daniel L Miller, et al.
The Journal of Urology|October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trialDavid M Schuster, Peter T Nieh, Ashesh B Jani, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptakeDavid M Schuster, Pooneh A Taleghani, Peter T Nieh, et al.
Pageof 1